Agenda:

8:15am - 8:45am  Registration & Networking

8:45am - 8:55am  Opening Remarks: Acknowledgements, Introductions, and Agenda 

9:00am - 9:30am  Current State of the Industry: Key Data from International, National, State, Regional markets

9:35am - 10:25am  Observational To Clinical: Where’s The Research?

10:30am - 11:25am  Improving Standards: Cannabis as a Medicine 

11:30am - 12:15pm Legal, Tax, and Insurance Considerations: USA vs. International Hemp and Cannabis Businesses 

12:15pm - 1:00pm  Lunch (boxed lunch provided for paid attendees) 

1:00pm - 1:30pm  Future State of the Industry: Key Data from International, National, State, Regional markets 

1:35pm - 2:25pm Technology Innovations Shaping the Industry: Compliance, Ag-tech, Med-Tech, Big Data

2:30pm - 3:20pm  International Commercialization: The Opportunity for Israel, USA, the Tri-State, and Pennsylvania  

3:20pm - 3:35pm  Bathroom and Coffee Break 

3:35pm - 4:25pm  Industrial Hemp Opportunities: Farmer, Investor, Researcher, and Processor 

4:30pm - 5:25pm  Cannabis and Hemp Investing: Private and Public Market Opportunities

5:30pm - 5:55pm  Lightning Pitches: Individual Company Presentations & Demonstrations 

5:55pm - 6:00pm  Closing Remarks: Calls to Action and Thank You 

6:00pm - 7:00pm  Networking Reception  

The Green Rush is exploding in 2019 and showing no signs of slowing down. Fueled by international  investments in the Canadian public markets,  merger-and-acquisition announcements by U.S.-based Multi-State Operators (MSOs),  and technology and research innovations pouring out of Israel, the  tri-state region is poising for the cannabis floodgates to open (read: Pennsylvania updates).  As the industry becomes more sophisticated and businesses become more dependent on outside growth-capital, the need for increased quality assurance, science-based efficacy, and consumer education is becoming paramount. 

Due to federal cannabis prohibition in the United States, American operators and investors are anticipated to continue to rely on strategic collaborations with international market leaders to advance research, knowledge-transfer, and technology commercialization efforts in an effort to remain at the forefront of cannabis innovation.   

Israel is well-known as the worldwide leader in medical cannabis research and technology innovation; however, it remains increasingly difficult for a country the size of New Jersey to transfer best practices to the global market at the rapid  pace the industry is currently demanding . As as result, there remains significant knowledge and capital gaps within the international cannabis ecosystem that lends itself to innovative service-providers working with forward-thinking economic-development and capital formation organizations to provide global solutions for cannabis business professionals.

Given Philadelphia's historical strengths  in sectors like  medical research, life sciences, and education, there is a once-in-a-lifetime opportunity for the City of Brotherly Love  to work hand-in-hand with Israel to put Southeast Pennsylvania on the map as the Medical Cannabis  Capital of the USA by positioning the region as a "landing pad" for international technology commercialization, knowledge transfer, and medical cannabis research.

Join us at Innovation In The Cannabis Industry to learn how this exciting industry will evolve in the tri-state area in 2019 and beyond, with a focus on how opportunities between Israel and Pennsylvania can be a catalyst of economic and workforce development, technology commercialization, medical research, and new investment for both regions.   

Innovation in the Cannabis Industry, From Israel to Philadelphia is proudly hosted by Greenhouse Ventures in partnership with the Philadelphia-Israel Chamber of Commerce.